Sirona Biochem Corp banner

Sirona Biochem Corp
XTSX:SBM

Watchlist Manager
Sirona Biochem Corp Logo
Sirona Biochem Corp
XTSX:SBM
Watchlist
Price: 0.06 CAD Market Closed
Market Cap: CA$15.8m

Wall St Price Targets

SBM Price Targets Summary
Sirona Biochem Corp

There are no price targets for SBM.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Sirona Biochem Corp Competitors:
Price Targets
LGI
Lgi Ltd
34% Upside
TTD
Trade Desk Inc
38% Upside
SMCP
SMCP SA
76% Upside
PTCT
PTC Therapeutics Inc
26% Upside
AYTU
Aytu Biopharma Inc
319% Upside
QLYS
Qualys Inc
28% Upside

Revenue
Forecast

20% / Year
Past Growth
244% / Year
Estimated Growth
Estimates Accuracy
-92%
Average Miss
20% / Year
Past Growth
244% / Year
Estimated Growth
Estimates Accuracy
-92%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 5 years is 244%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SBM's stock price target?
Not Available

SBM does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Sirona Biochem Corp?
Projected CAGR
244%

Over the last 8 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 5 years is 244%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett